No. 24-270

Vanda Pharmaceuticals Inc. v. Centers for Medicare & Medicaid Services, et al.

Lower Court: Fourth Circuit
Docketed: 2024-09-10
Status: Denied
Type: Paid
Experienced Counsel
Tags: administrative-law agency-interpretation line-extension medicaid-rebate new-drug-application statutory-construction
Latest Conference: 2025-01-10
Question Presented (from Petition)

1. Does a decision that upholds an agency statutory interpretation merely because it is "perfectly sensible" or "reasonable and consistent with the statutory framework" comport with Loper Light Enterprises v. Raimondo, 144 S. Ct. 2244 (2024)?

2. Is an agency free to disregard reliance interests engendered by its prior interpretation of the statute it administers simply because that interpretation was announced in a non-binding document like a notice of proposed rulemaking?

Question Presented (AI Summary)

Does a decision upholding an agency's statutory interpretation merely because it is 'perfectly sensible' comport with Loper Bright Enterprises v. Raimondo, and can an agency disregard prior reliance interests by reinterpreting a statute?

Docket Entries

2025-01-13
Petition DENIED.
2024-12-24
DISTRIBUTED for Conference of 1/10/2025.
2024-12-23
Reply of Vanda Pharmaceuticals submitted.
2024-12-23
Reply of petitioner Vanda Pharmaceuticals filed. (Distributed)
2024-12-23
2024-12-05
Brief of respondents United States, et al. in opposition filed.
2024-10-21
Motion to extend the time to file a response is granted and the time is further extended to and including December 5, 2024.
2024-10-18
Motion to extend the time to file a response from November 12, 2024 to December 5, 2024, submitted to The Clerk.
2024-09-19
Motion to extend the time to file a response is granted and the time is extended to and including November 12, 2024. See Rule 30.1.
2024-09-18
Motion to extend the time to file a response from October 10, 2024 to November 11, 2024, submitted to The Clerk.
2024-09-06
2024-06-11
Application (23A1105) granted by The Chief Justice extending the time to file until September 6, 2024.
2024-06-07
Application (23A1105) to extend the time to file a petition for a writ of certiorari from July 9, 2024 to September 6, 2024, submitted to The Chief Justice.

Attorneys

United States
Elizabeth B. Prelogar — Respondent
Vanda Pharmaceuticals
Paul Whitfield HughesMcDermott Will & Emery, Petitioner